Amoeba S.A.
Basic Materials · EUR · EPA
Price
€0.872
Cap
€5.52M
Earnings
—
30d Trend
+2.6%
54% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 33×Macro 0.99 (−1%)=33
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Amoeba S.A. at 33/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 42/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-2.5%
3 MONTHS
-15.7%
12 MONTHS
-25.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Technical (42) and low-risk profile are the primary strengths. I note that quality is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 54%. I classify this as a speculative position — elevated volatility at 54% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.